Language：English   Publishing type：Research paper (scientific journal)   Publisher：SAGE Publications  

Background

The utility of a clinical decision support system using a machine learning (ML) model for simultaneous cardiac and pulmonary auscultation is unknown.

Objective

This study aimed to develop and evaluate an ML system's utility for cardiopulmonary auscultation.

Methods

First, we developed an ML system for cardiopulmonary auscultation, using cardiopulmonary sound files from our previous study. The technique involved pre-processing, feature extraction, and classification through several neural network layers. After integration, the output class was categorized as “normal,” “abnormal,” or “undetermined.” Second, we evaluated the ML system with 24 junior residents in an open-label randomized controlled trial at a university hospital. Participants were randomly assigned to the ML system group (intervention) or conventional auscultation group (control). During training, participants listened to four cardiac and four pulmonary sounds, all of which were correctly classified. Then, participants classified a series of 16 simultaneous cardiopulmonary sounds. The control group auscultated the sounds using noise-cancelling headphones, while the intervention group did so by watching recommendations from the ML system.

Results

The total scores for correctly identified normal or abnormal cardiopulmonary sounds in the intervention group were significantly higher than those in the control group (366/384 [95.3%] vs. 343/384 [89.3%], P = 0.003). The cardiac test score in the intervention group was better (111/192 [57.8%] vs. 90/192 [46.9%], P = 0.04); there was no significant difference in pulmonary auscultation.

Conclusions

The ML-based system improved the accuracy of cardiopulmonary auscultation for junior residents. This result suggests that the system can assist early-career physicians in accurate screening.

DOI： 10.1177/20552076241233689

PubMed

researchmap

Other Link： http://journals.sagepub.com/doi/full-xml/10.1177/20552076241233689

Publishing type：Research paper (scientific journal)   Publisher：JMIR Publications Inc.  

DOI： 10.2196/55627

researchmap

Authorship：Lead author   Language：English   Publishing type：Research paper (scientific journal)   Publisher：MDPI AG  

Background: Although many adverse reactions after SARS-CoV-2 vaccination have been reported, there have been few comprehensive studies on persistent symptoms after SARS-CoV-2 vaccination. The aim of this study was to determine the clinical characteristics of patients with various persistent symptoms after SARS-CoV-2 vaccination. Methods: A retrospective descriptive study was performed for patients who visited a specialized clinic established at Okayama University Hospital to evaluate adverse events after SARS-CoV-2 vaccination during the period from April 2021 to March 2023. Results: Descriptive analysis was performed for 121 of 127 patients who visited the clinic during the study period, and separate analysis was performed for the other 6 patients who had serious complications, who required treatment with prednisolone, and who had persistent symptoms. The median [interquartile range] age of the patients was 48 years [31–64 years], and the patients included 44 males (36.4%) and 77 females (63.6%). The most frequent symptoms were sensory impairment (34 patients, 28.1%), general fatigue (30 patients, 24.8%), fever/low-grade fever (21 patients, 17.4%), and headache (21 patients, 17.4%). Serious complications included myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), sarcoidosis, aseptic meningitis, neuromyelitis optica spectrum disorders (NMOSDs), tendon adhesions, and idiopathic thrombocytopenia. Conclusions: Although causal relationships were not determined, 15 persistent symptoms after SARS-CoV-2 vaccination were characterized. All of the symptoms had onset from 12 hours to one week after vaccination, with 10 symptoms persisting for 6 months or longer. The most frequent symptom was sensory impairment.

DOI： 10.3390/vaccines11111661

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：JMIR Publications Inc.  

BACKGROUND: The diagnostic accuracy of differential diagnoses generated by artificial intelligence chatbots, including ChatGPT models, for complex clinical vignettes derived from general internal medicine (GIM) department case reports is unknown. OBJECTIVE: This study aims to evaluate the accuracy of the differential diagnosis lists generated by both third-generation ChatGPT (ChatGPT-3.5) and fourth-generation ChatGPT (ChatGPT-4) by using case vignettes from case reports published by the Department of GIM of Dokkyo Medical University Hospital, Japan. METHODS: We searched PubMed for case reports. Upon identification, physicians selected diagnostic cases, determined the final diagnosis, and displayed them into clinical vignettes. Physicians typed the determined text with the clinical vignettes in the ChatGPT-3.5 and ChatGPT-4 prompts to generate the top 10 differential diagnoses. The ChatGPT models were not specially trained or further reinforced for this task. Three GIM physicians from other medical institutions created differential diagnosis lists by reading the same clinical vignettes. We measured the rate of correct diagnosis within the top 10 differential diagnosis lists, top 5 differential diagnosis lists, and the top diagnosis. RESULTS: In total, 52 case reports were analyzed. The rates of correct diagnosis by ChatGPT-4 within the top 10 differential diagnosis lists, top 5 differential diagnosis lists, and top diagnosis were 83% (43/52), 81% (42/52), and 60% (31/52), respectively. The rates of correct diagnosis by ChatGPT-3.5 within the top 10 differential diagnosis lists, top 5 differential diagnosis lists, and top diagnosis were 73% (38/52), 65% (34/52), and 42% (22/52), respectively. The rates of correct diagnosis by ChatGPT-4 were comparable to those by physicians within the top 10 (43/52, 83% vs 39/52, 75%, respectively; P=.47) and within the top 5 (42/52, 81% vs 35/52, 67%, respectively; P=.18) differential diagnosis lists and top diagnosis (31/52, 60% vs 26/52, 50%, respectively; P=.43) although the difference was not significant. The ChatGPT models' diagnostic accuracy did not significantly vary based on open access status or the publication date (before 2011 vs 2022). CONCLUSIONS: This study demonstrates the potential diagnostic accuracy of differential diagnosis lists generated using ChatGPT-3.5 and ChatGPT-4 for complex clinical vignettes from case reports published by the GIM department. The rate of correct diagnoses within the top 10 and top 5 differential diagnosis lists generated by ChatGPT-4 exceeds 80%. Although derived from a limited data set of case reports from a single department, our findings highlight the potential utility of ChatGPT-4 as a supplementary tool for physicians, particularly for those affiliated with the GIM department. Further investigations should explore the diagnostic accuracy of ChatGPT by using distinct case materials beyond its training data. Such efforts will provide a comprehensive insight into the role of artificial intelligence in enhancing clinical decision-making.

DOI： 10.2196/48808

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

DOI： 10.1507/endocrj.EJ23-0266

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

OBJECTIVE: The most common symptom of post-acute coronavirus disease 2019 (COVID-19) is fatigue, and it potentially leads to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS); however, a specific prognosticator is lacking. We aimed to elucidate the clinical characteristics of patients who developed ME/CFS after COVID-19. METHODS: In this retrospective observational study, patients who visited Okayama University Hospital for long COVID between February 2021 and March 2022 were investigated. RESULTS: Of the 234 patients, 139 (59.4%) had fatigue symptoms. Fifty patients with fatigue symptoms (21.4%) met the criteria for ME/CFS (ME/CFS group), while the other 89 patients did not (non-ME/CFS group); 95 patients had no fatigue complaints (no-fatigue group). Although the patients' backgrounds were not significantly different between the three groups, the ME/CFS group presented the highest scores on the self-rating symptom scales, including the Fatigue Assessment Scale (FAS), EuroQol, and the Self-Rating Depression Scale (SDS). Furthermore, serum ferritin levels, which were correlated with FAS and SDS scores, were significantly higher in the ME/CFS group (193.0 μg/L, interquartile range (IQR): 58.8-353.8) than in the non-ME/CFS group (98.2 μg/L, 40.4-251.5) and no-fatigue group (86.7 μg/L, 37.5-209.0), and a high serum ferritin level was prominent in female patients. Endocrine workup further showed that the ME/CFS group had higher thyrotropin levels but lower growth hormone levels in serum and that insulin-like growth factor-I levels were inversely correlated with ferritin levels (R = -0.328, p < 0.05). CONCLUSIONS: Serum ferritin level is a possible predictor of the development of ME/CFS related to long COVID, especially in female patients.

DOI： 10.3390/jcm12144737

PubMed

researchmap

Language：Japanese  

J-GLOBAL

researchmap

Language：English  

Here we report a case of sarcoidosis which demonstrated with bilateral ankle arthritis. We usually do not consider sarcoidosis routinely for the differential diagnosis of acute arthritis, however, up to 15 to 25% of sarcoidosis complicate arthritis, typically in ankle joints. Sarcoid arthritis is reported to occur mainly in young northern Europe women, whereas this case intimate that we should take sarcoidosis into account as the differential diagnosis of ankle arthralgia also among Asian men especially when combining upper respiratory symptoms.

DOI： 10.1002/jgf2.621

PubMed

researchmap

Language：Japanese  

J-GLOBAL

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Objectives: The present study aimed to elucidate the characteristics of long COVID patients with headaches. Methods: A single-center retrospective observational study was performed for long COVID outpatients who visited our hospital from 12 February 2021 to 30 November 2022. Results: A total of 482 long COVID patients, after excluding 6, were divided into two groups: the Headache group of patients with complaints of headache (113 patients: 23.4%) and the remaining Headache-free group. Patients in the Headache group were younger (median age: 37 years) than patients in the Headache-free group (42 years), while the ratio of females (56%) in the Headache group was nearly the same as that in the Headache-free group (54%). The proportion of patients in the Headache group who were infected in the Omicron-dominant phase (61%) was larger than the proportions of patients infected in the Delta (24%) and preceding (15%) phases, and that trend was significantly different from the trend in the Headache-free group. The duration before the first visit for long COVID was shorter in the Headache group (71 days) than in the Headache-free group (84 days). The proportions of patients in the Headache group with comorbid symptoms, including general fatigue (76.1%), insomnia (36.3%), dizziness (16.8%), fever (9.7%), and chest pain (5.3%) were larger than the proportions of patients in the Headache-free group, whereas blood biochemical data were not significantly different between the two groups. Interestingly, patients in the Headache group had significant deteriorations of scores indicating depression and scores for quality of life and general fatigue. In multivariate analysis, headache, insomnia, dizziness, lethargy, and numbness were shown to be involved in the quality of life (QOL) of long COVID patients. Conclusions: The manifestation of headaches related to long COVID was found to have a significant impact on social and psychological activities. Alleviation of headaches should be a priority for the effective treatment of long COVID.

DOI： 10.3390/jcm12103533

PubMed

researchmap

Language：Japanese   Publisher：(一社)日本内分泌学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本内分泌学会  

J-GLOBAL

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

OBJECTIVES: The aim of this study was to determine the characteristics of hypozincemia in long COVID patients. METHODS: This study was a single-center retrospective observational study for outpatients who visited the long COVID clinic established in a university hospital during the period from 15 February 2021 to 28 February 2022. Characteristics of patients with a serum zinc concentration lower than 70 μg/dL (10.7 μmol/L) were compared with characteristics of patients with normozincemia. RESULTS: In a total of 194 patients with long COVID after excluding 32 patients, hypozincemia was detected in 43 patients (22.2%) including 16 male patients (37.2%) and 27 female patients (62.8%). Among various parameters including the background characteristics of the patients and medical histories, the patients with hypozincemia were significantly older than the patients with normozincemia (median age: 50 vs. 39 years). A significant negative correlation was found between serum zinc concentrations and age in male patients (R = -0.39; p < 0.01) but not in female patients. In addition, there was no significant correlation between serum zinc levels and inflammatory markers. General fatigue was the most frequent symptom in both male patients with hypozincemia (9 out of 16: 56.3%) and female patients with hypozincemia (8 out of 27: 29.6%). Patients with severe hypozincemia (serum zinc level lower than 60 μg/dL) had major complaints of dysosmia and dysgeusia, which were more frequent complaints than general fatigue. CONCLUSIONS: The most frequent symptom in long COVID patients with hypozincemia was general fatigue. Serum zinc levels should be measured in long COVID patients with general fatigue, particularly in male patients.

DOI： 10.3390/jcm12052062

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Background: Since the start of the global pandemic of coronavirus disease 2019 (COVID-19), not only adults but also many children have suffered from it. However, the clinical characteristics of long COVID in children remain unclear. Methods: In this retrospective observational study conducted in a single facility, we reviewed the medical records of all long COVID patients who visited Okayama University Hospital from February 2021 to October 2022, and we compared the clinical characteristics of long COVID in teenagers (11 to 18 years of age) with those in adults. Results: Data for 452 long COVID patients including 54 teenagers (11.9%) were analyzed. Fatigue was the most frequent symptom in teenagers (55.6% of the patients) and also in adults. On the other hand, the percentage of teenagers who complained of headache, which was the second most frequent complaint, was significantly higher than the percentage of adults (35.2% vs. 21.9%, p < 0.05). A comparison of the frequencies of symptoms depending on the viral variant showed that fatigue and headache were predominant symptoms in the Omicron variant phase. Of the 50 teenagers who were enrolled in schools, 28 (56.0%) could not attend school due to long COVID symptoms. The most common symptoms as reasons for absence from school were fatigue (85.7% of the patients), headache (42.9%), and insomnia (32.1%). Conclusions: Attention should be paid to the symptoms of fatigue and headache in teenagers with long COVID.

DOI： 10.3390/medicina59020261

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

BACKGROUND: Excessive psychological stress in medical students affects their mental health and causes problems such as burnout and depression. Furthermore, changes in the learning environment to online learning due to the COVID-19 pandemic have had a psychological effect on medical students. However, the relationships between medical students' perceived stress and different methods of communication, including in-person and online communication, remain unclear. The purpose of this study was to investigate the differences in stress perception of medical students depending on in-person communication and online communication during the COVID-19 pandemic. METHODS: This study was a cross-sectional study conducted from September to October in 2020. All of the students of Okayama University School of Medicine were asked to participate in a questionnaire survey. The explanatory variables were the frequency and length of communications with others (by in-person or online communication), empathy, and lifestyle. The main outcome measure was perceived stress. Subgroup analysis was conducted for students who preferred to be by themselves and students who preferred to study together and interact with other people. Univariate analysis and multivariate multiple regression analysis were conducted. Gender and grade, which have been shown to be associated with stress in previous studies, were used as covariates for multiple regression analysis. RESULTS: Valid responses to the questionnaire survey were received from 211 (29.4%) of the 717 students. There was no significant association between perceived stress and online communication, but the number of people with which students had in-person communication (1-2 people compared to 0 as a control, regression coefficient [B] = -4.4, 95% confidence interval [CI]; -7.8, -1.1, more than 10 people, B = -12, 95% CI: -18, -5.8) and the length of communication (more than 120 min, B = -4.5, 95% CI: -8.1, -0.92) were associated with a reduction in perceived stress. In subgroup analysis, the number of people with in-person communication and the length of communication had significant associations with stress reduction even in the group of students who had a preference for being by themselves. CONCLUSION: In-person communications rather than online communications were associated with a lower level of perceived stress. In subgroup analysis, this trend was statistically significant in the group of students who had a preference for being by themselves.

DOI： 10.3390/ijerph20021579

PubMed

researchmap

Language：Japanese   Publishing type：Research paper (scientific journal)  

The recruitment and training of early-career researchers are important for the development of science, especially in countries with low birth rates, such as Japan. In several academic societies for social medicine, early-career researchers have formed associations for the purposes of networking and career development. However, to date, little information about the activities of these associations has been shared. Therefore, we organized a symposium at the 93rd Annual Meeting of the Japanese Society for Hygiene (March 4, 2023) to introduce the early-career researcher associations that have been formed within five academic societies namely the Japanese Society for Hygiene, Japan Epidemiological Association, Japan Society for Occupational Health, Japan Society for Medical Education, and Japan Society for Healthcare Administration. In this paper, we summarize the activities, challenges, and future prospects of each association and their strategies for future development and collaboration on the basis of presentations and discussions at the symposium.

DOI： 10.1265/jjh.23005

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

OBJECTIVES: The objective of this study was to determine the clinical and endocrinological features of sleep disturbance in patients with long COVID. METHODS: This study was a single-center retrospective observational study for patients who visited the COVID-19 aftercare outpatient clinic (CAC) established in Okayama University Hospital in Japan during the period from 15 February 2021 to 29 July 2022. The long COVID patients were divided into two groups based on the presence or absence of sleep disturbance, and the clinical and laboratory characteristics of the patients were analyzed. RESULTS: Out of 363 patients with long COVID, after excluding 6 patients, 60 patients (16.5%) (55% males, median age of 38 years) complaining of sleep disturbance were compared with 303 patients (83.5%) (43% males, median age of 40 years) without sleep-related symptoms. Although there were no significant differences in clinical backgrounds and severities of COVID-19 between the two groups by the multivariate analysis, the percentage of long COVID patients with sleep disturbance was significantly increased among patients infected in the Omicron-dominant phase. In addition, the prevalence rate of sleep disturbance in patients when infected in the Omicron phase (24.8%) was two-times higher than that in patients infected in the Delta phase (12.8%). Of note, the percentages of patients with sleep disturbance who also complained of general fatigue, headache, concentration loss, anxiety, low-grade fever, and brain fog symptoms were higher than the percentages of patients without sleep disturbance who had the same complaints. Among the types of sleep disturbance, the percentage of patients who complained of loss of sleep induction (75%) was much higher than the percentage of patients with early-awakening sleep disturbance (6.7%), and many of the patients with mid-awakening types of insomnia had brain fog symptoms. Endocrine examinations revealed that long COVID patients with sleep disturbance had significantly higher levels of plasma adrenocorticotropin and lower levels of serum growth hormone, suggesting the presence of hypothalamic-pituitary stress. CONCLUSION: The prevalence of sleep disturbance has been increasing in long COVID patients infected in the Omicron phase with a certain clinical and endocrine trend.

DOI： 10.3390/jcm11247332

PubMed

researchmap

Language：Japanese   Publisher：(一社)日本糖尿病学会  

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：MDPI  

Background and Objectives: Changes in post COVID-19 condition (PCC) characteristics caused by viral variants have yet to be clarified. We aimed to characterize the differences between clinical backgrounds and manifestations in long COVID patients who were infected with the Delta variant and those who were infected with the Omicron variants. Materials and Methods: This study was a single-center retrospective observational study for patients who visited our COVID-19 aftercare outpatient clinic (CAC) established in Okayama University Hospital (Japan) during the period from 15 February 2021 to 15 July 2022. We classified the onset of COVID-19 in the patients into three groups, the preceding, Delta-dominant, and Omicron-dominant periods, based on the prevalent periods of the variants in our prefecture. Results: In a total of 353 patients, after excluding 8 patients, 110, 130, and 113 patients were classified into the preceding, Delta-dominant, and Omicron-dominant periods, respectively. Patients infected in the Omicron-dominant period had significantly fewer hospitalizations, milder illnesses, more vaccinations and earlier visit to the CAC than did patients infected in the Delta-dominant period. Patients infected in the Omicron-dominant period had significantly lower frequencies of dysosmia (12% vs. 45%, ** p &lt; 0.01), dysgeusia (14% vs. 40%, ** p &lt; 0.01) and hair loss (7% vs. 28%, ** p &lt; 0.01) but had higher frequencies of fatigue (65% vs. 50%, * p &lt; 0.05), insomnia (26% vs. 13%, * p &lt; 0.05) and cough (20% vs. 7%, ** p &lt; 0.01) than did patients infected in the Delta-dominant period. Conclusions: The transitional changes in long COVID symptoms caused by the two variants were characterized.

DOI： 10.3390/medicina58101393

Web of Science

PubMed

researchmap

Authorship：Lead author   Language：English   Publishing type：Research paper (scientific journal)   Publisher：{MDPI} {AG}  

Background and Objectives: COVID-19 can be serious not only in the acute phase but also after the acute phase and some patients develop ME/CFS. There have been few studies on patients with long COVID in whom ME/CFS was diagnosed by physicians based on standardized criteria after examinations and exclusion diagnosis and not based on only subjective symptoms. The purpose of this study was to elucidate the detailed characteristics of ME/CFS in patients with long COVID. Materials and Methods: A retrospective descriptive study was performed for patients who visited a COVID-19 aftercare clinic established in Okayama University Hospital during the period was from February 2021 to April 2022. Results: Clinical data were obtained from medical records for 281 patients, and 279 patients who met the definition of long COVID were included. The overall prevalence rate of ME/CFS diagnosed by three sets of ME/CFS criteria (Fukuda, Canadian and IOM criteria) was 16.8% (48.9% in male and 51.1% in females). The most frequent symptoms in ME/CFS patients were general fatigue and post-exertional malaise (89.4% of the patients), headache (34.0%), insomnia (23.4%), dysosmia (21.3%) and dysgeusia (19.1%). Dizziness, chest pain, insomnia and headache were characteristic symptoms related to ME/CFS. The male to female ratio in ME/CFS patients was equal in the present study, although ME/CFS was generally more common in women in previous studies. Given that patients with ME/CFS had more severe conditions in the acute phase of COVID-19, the severity of the acute infectious state might be involved in the pathophysiology of ME/CFS. Conclusions: The prevalence rate of ME/CFS and the characteristic sequelae in the long COVID condition were revealed in this study.

DOI： 10.3390/medicina58070850

Web of Science

PubMed

researchmap

Authorship：Lead author   Language：English   Publishing type：Research paper (scientific journal)   Publisher：MDPI  

Evidence regarding treatment for the acute phase of COVID-19 has been accumulating, but specific treatment for long COVID/post-COVID-19 condition has not yet been established. Treatment with herbal medicine might be one treatment option for long COVID, but there has been little research on the effectiveness of herbal medicine for long COVID. The aim of this study was to clarify the prescription patterns of Kampo medicines, which are herbal medicines that originated in China and were developed in Japan, for the treatment of general fatigue due to long COVID. A retrospective descriptive study was performed for patients who visited a COVID-19 aftercare clinic established in Okayama University Hospital during the period from Feb 2021 to Dec 2021 with a focus on symptoms accompanying general fatigue and prescriptions of Kampo medicine. Among the clinical data obtained from medical records of 195 patients, clinical data for 102 patients with general fatigue and accompanying symptoms were analyzed. The patients had various symptoms, and the most frequent symptoms accompanying general fatigue were dysosmia, dysgeusia, headache, insomnia, dyspnea, and hair loss. Prescriptions of Kampo medicine accounted for 24.1% of the total prescriptions (n = 609). The most frequently prescribed Kampo medicine was hochuekkito (71.6%) and other prescribed Kampo medicines were tokishakuyakusan, ryokeijutsukanto, juzentaihoto, hangekobokuto, kakkonto, ninjin'yoeito, goreisan, rikkunshito, and keishibukuryogan. Since the pathophysiology of general fatigue after an infectious disease is, in general, considered a qi deficiency in Kampo medicine, treatments with such compensation agents can be the major prescription as a complement for the qi. In conclusion, Kampo medicine can be one of the main pharmacological treatments for long COVID accompanying general fatigue.

DOI： 10.3390/medicina58060730

Web of Science

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：JAPAN ENDOCRINE SOC  

Symptoms of long COVID are complex and long-lasting, and endocrine dysfunction might be involved in the underlying mechanisms. In this study, to clarify the hormonal characteristics of long COVID patients, laboratory data for patients who visited the outpatient clinic for long COVID were evaluated. A retrospective analysis was performed for patients who visited Okayama University Hospital during the period from Feb 2021 to Dec 2021 with focus on the interrelationships between major symptoms and endocrine data. Information and laboratory data were obtained from medical records for 186 patients. The patients had various symptoms, and the most frequent symptoms were general malaise, dysosmia/dysgeusia, hair loss, headache, dyspnea, and sleeplessness. Patients who were suffering from fatigue and dysosmia/dysgeusia were younger, while hair loss was more frequent in older and female patients. As for the characteristics of patients suffering from general fatigue, the scores of depression and fatigue were positively correlated with serum levels of cortisol and free thyroxin (FT4), respectively. Also, patients suffering from general fatigue had lower levels of serum growth hormone and higher levels of serum FT4, while patients with dysosmia/dysgeusia had a significantly lower level of serum cortisol. Serum thyrotropin (TSH) levels were higher and the ratios of FT4/TSH were lower in the initially severe cases, suggesting occult hypothyroidism. In addition, the ratios of plasma adrenocorticotropin to serum cortisol were decreased in patients with relatively high titers of serum SARS-CoV-2 antibody. Thus, hormonal changes seem to be, at least in part, involved in the persistent symptoms of long COVID.

DOI： 10.1507/endocrj.EJ22-0093

Web of Science

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：MDPI  

After the acute phase of COVID-19, some patients have been reported to have persistent symptoms including general fatigue. We have established a COVID-19 aftercare clinic (CAC) to provide care for an increasing number of these patients. Here, we report the case of a 36-year-old man who developed post-COVID fatigue after acute infection with SARS-CoV-2. In the acute phase of COVID-19, the patient's fever resolved within four days; however, general fatigue persisted for three months, and he visited our CAC 99 days after the initial infection. Examination revealed a high Aging Male's Symptoms (AMS) score of 44 and low free testosterone (FT) level of 5.5 pg/mL, which meet the Japanese criteria of late-onset hypogonadism (LOH) syndrome. Imaging studies revealed an atrophic pituitary in addition to fatty liver and low bone mineral density. Anterior pituitary function tests showed a low follicle-stimulating hormonelevel and delayed reaction of luteinizing hormone (LH) after gonadotropin-releasing hormone (GnRH) stimulation, indicating the possibility of hypothalamic hypogonadism in addition to primary hypogonadism seen in patients with post-COVID-19 conditions. After the initiation of Japanese traditional medicine (Kampo medicine: hochuekkito followed by juzentaihoto), the patient's symptoms as well as his AMS score and serum FT level were noticeably improved. Furthermore, follow-up tests of GnRH stimulation revealed improvements in LH responsiveness. Although many patients have been reported to meet the criteria of ME/CFS such as our case, we emphasize the possibility of other underlying pathologies including LOH syndrome. In conclusion, LOH syndrome should be considered a cause of general fatigue in patients with post-COVID-19 conditions and herbal treatment might be effective for long COVID symptoms due to LOH (264 words).

DOI： 10.3390/medicina58040536

Web of Science

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：WILEY  

Calcimimetic treatment has been reported to be effective for primary hyperparathyroidism (PHPT). Nine elderly PHPT patients who had been treated with calcimimetics were retrospectively analyzed. It was found that calcimimetics can reduce elevated serum calcium levels in elderly PHPT patients with low femoral DEXA %YAM and low urinary cAMP levels.

DOI： 10.1002/ccr3.5713

Web of Science

PubMed

researchmap

Language：Japanese  

J-GLOBAL

researchmap

Other Link： https://search-tp.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2022&ichushi_jid=J00050&link_issn=&doc_id=20220513070002&doc_link_id=%2Fed9jmded%2F2022%2F005302%2F002%2F0157-0162%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fed9jmded%2F2022%2F005302%2F002%2F0157-0162%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

Language：English   Publishing type：Research paper (scientific journal)   Publisher：MDPI  

The pathogenesis and prognosis of post COVID-19 condition have remained unclear. We set up an outpatient clinic specializing in long COVID in February 2021 and we have been investigating post COVID-19 condition. Based on the results of our earlier study showing that "general fatigue" mimicking myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is the most common symptom in long COVID patients, a retrospective analysis was performed for 39 male patients in whom serum free testosterone (FT) levels were measured out of 61 male patients who visited our clinic. We analyzed the medical records of the patients' backgrounds, symptoms and laboratory results. Among the 39 patients, 19 patients (48.7%) met the criteria for late-onset hypogonadism (LOH; FT &lt; 8.5 pg/mL: LOH group) and 14 patients were under 50 years of age. A weak negative correlation was found between age and serum FT level (r = -0.301, p = 0.0624). Symptoms including general fatigue, anxiety, cough and hair loss were more frequent in the LOH group than in the non-LOH group (FT ≥ 8.5 pg/mL). Among various laboratory parameters, blood hemoglobin level was slightly, but significantly, lower in the LOH group. Serum level of FT was positively correlated with the levels of blood hemoglobin and serum total protein and albumin in the total population, whereas these interrelationships were blurred in the LOH group. Collectively, the results indicate that the incidence of LOH is relatively high in male patients, even young male patients, with post COVID-19 and that serum FT measurement is useful for revealing occult LOH status in patients with long COVID.

DOI： 10.3390/jcm11071955

Web of Science

PubMed

researchmap

Language：Japanese   Publisher：(一社)日本感染症学会  

初期研修医の卒後ローテーションにおける「感染症研修の必須化」に関する意識などを明らかにすることを目的に、岡山県内で初期研修プログラムを有する16の研修病院に所属する初期研修医(卒後1・2年)、および専攻医(卒後3・4・5年)を対象にウェブ・アンケートを行い、127名(男性64名、女性60名、無回答3名)より回答を得た。その結果、初期研修医制度における「感染症研修の必須化」(例:最低1ヵ月ローテーションするなど)について84名(66.1%)が賛成すると回答した。一方、18名(14.2%)は必須化に反対しており、その理由として、「ローテーション選択の自由度を損なうため」(15名)などが挙げられた。

researchmap

Other Link： https://search-tp.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2022&ichushi_jid=J00276&link_issn=&doc_id=20220406400006&doc_link_id=1390010292792199424&url=https%3A%2F%2Fcir.nii.ac.jp%2Fcrid%2F1390010292792199424&type=CiNii&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00003_3.gif

Language：English   Publishing type：Research paper (scientific journal)   Publisher：MDPI  

BACKGROUND: Various symptoms persist even after the acute symptoms in about one third of patients with COVID-19. In February 2021, we established an outpatient clinic in a university hospital for patients with long COVID and started medical treatment for sequelae that persisted one month or more after infection. METHODS: To determine the key factors that affect the onset and clinical course of sequelae, a retrospective analysis was performed at Okayama University Hospital (Japan) between February and July 2021. We focused on changes in the numbers of symptoms and the background of the patients during a three-month period from the first outpatient visit. We also examined the relationship with SARS-CoV-2 antibody titers. RESULTS: Information was obtained from medical records for 65 patients. The symptoms of sequelae were diverse, with more than 20 types. The most frequent symptoms were general malaise, dysosmia, dysgeusia, sleeplessness, and headache. These symptoms improved in about 60% of the patients after 3 months. Patients who required hospitalization and had a poor condition in the acute phase and patients who received oxygen/dexamethasone therapy had higher antibody titers at the time of consultation. Patients with antibody titers ≥200 U/mL showed significantly fewer improvements in long COVID symptoms in 1 month, but they showed improvements at 3 months after the first visit. CONCLUSION: Long COVID symptoms were improved at 3 months after the initial visit in more than half of the patients. Serum antibody titers were higher in patients who experienced a severe acute phase, but the serum antibody titers did not seem to be directly related to the long-term persistence of long COVID symptoms.

DOI： 10.3390/jcm11051309

Web of Science

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：CUREUS INC  

Herein, we report a remarkable case of post-coronavirus disease 2019 (COVID-19) diffuse alopecia that gradually improved and recovered, and the hair volume returned approximately to the pre-infection level, seven months after the patient's first diagnosis of COVID-19. Approximately 20% of patients with COVID-19 develop alopecia a few months after the acute infection phase. Telogen effluvium is the major type of COVID-19 sequela secondary to physical or psychological distress. It is reversible and is expected to improve without any treatment, and it can be addressed by explaining to the patients their conditions, sharing medical information, and eliminating psychophysical stress by managing systemic complications.

DOI： 10.7759/cureus.21160

Web of Science

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：PUBLIC LIBRARY SCIENCE  

INTRODUCTION: The emergence of the novel coronavirus disease of 2019 (COVID-19) has led to huge disruptions in the medical field and society. The significance of training and education for experts has been increasingly acknowledged in Japan, where the number of infectious disease (ID) specialists is reportedly insufficient. In this paper, we report the results of a web-based survey that was conducted to reveal the ways in which the COVID-19 pandemic has influenced medical students' awareness of ID specialists and future career choices. METHOD: This cross-sectional descriptive study was conducted in March 2021 and targeted 717 medical students belonging to Medical School of Okayama University, Japan. The questionnaire consisted of four questions meant to assess students' knowledge and future intentions of becoming ID specialists. RESULTS: We obtained 328 eligible questionnaires (response rate: 45.7%). Of 227 (69.2%) students who were aware of ID specialists, 99 (43.6%) answered that they came to know about them only after the pandemic, 12 (3.7%) answered that their interest in being an ID specialist arose during the pandemic, while 36 (11.0%) responded that they would rather not become ID specialists. At the time of the survey, 5 students (1.5%) were aiming to become ID specialists. CONCLUSION: We observed a very low rate of interest to be an ID specialist among medical students. The experience of the pandemic does not seem to have influenced Japanese medical students to choose ID as a specialty for their careers. Continuous efforts to increase the number of ID specialists are necessary in Japan as a countermeasure against the coming pandemic.

DOI： 10.1371/journal.pone.0267587

Web of Science

PubMed

researchmap

Language：Japanese  

J-GLOBAL

researchmap

Authorship：Lead author   Language：English   Publishing type：Research paper (scientific journal)   Publisher：BMJ PUBLISHING GROUP  

A 42-year-old man who had suffered from severe fatigue for 5 years was diagnosed as having chronic fatigue syndrome (CFS) and fibromyalgia. Endocrinological workup using combined anterior pituitary function tests showed that the patient had adrenocorticotropin hormone (ACTH) deficiency, with a normal pituitary MRI. Treatment with a physiologic dose of oral hydrocortisone replacement physically ameliorated his general fatigue. A secondary workup using a growth hormone-releasing peptide-2 test revealed that he also had growth hormone (GH) deficiency, and GH replacement therapy was started. His muscle pain and depression were improved by the therapy. Here, we present a rare case of combined deficiency of ACTH and GH in a middle-aged man with severe general fatigue. This case report aims to raise awareness of combined deficiency of ACTH and GH as a differential diagnosis of CFS and its mimics.

DOI： 10.1136/bcr-2021-244861

Web of Science

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：CUREUS INC  

Introduction The long-term clinical course, prognosis, and optimal management of symptoms and conditions after the acute phase of coronavirus disease 2019 (COVID-19) remain to be elucidated. The purpose of this study was to clarify the characteristics of patients referred to a COVID-19 aftercare (CAC) clinic established at a tertiary academic hospital in Japan. Methods This study was a descriptive case series study. All patients who visited the CAC clinic between February 15 and September 17 in 2021 were included. Patients' background, chief complaints, and clinical courses after the onset of COVID-19 were described. Results A total of 87 Japanese patients (median age, 40.0 years; interquartile range [IQR], 26.5-53.0 years; 52.9% women) were referred to the CAC clinic. The median interval between the onset of COVID-19 and the visit to the clinic was 79.0 (IQR, 52.5-112.0) days. Referral sources were hospitals (36 patients), clinics (47 patients), a local healthcare center (3 patients), and other (1 patient). The most common chief complaint was general fatigue (50.4%) followed by dysosmia (28.7%), dysgeusia (26.4%), hair loss (18.4%), headache (17.2%), dyspnea (16.1%), and dyssomnia (13.1%). Respiratory symptoms were common in the early stages of the disease but were less common as the chief complaints when visiting the clinic. On the other hand, neurological, psychiatric, and extremity symptoms were predominant one month after the onset of COVID-19. Conclusions Regardless of the severity in the acute phase, patients visiting our CAC clinic suffered from a variety of symptoms. General physicians skilled in using a comprehensive approach would be optimal to see patients with such complex symptoms.

DOI： 10.7759/cureus.18568

Web of Science

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：CUREUS INC  

Y ObjectivesVitamin D deficiency, which is common worldwide, increases the risks of falls and fractures and can lead to increased morbidity and mortality. However, the clinical utility and relevance of vitamin D activation remain unknown. The aim of the present study was to clarify the clinical usefulness of serum 1,25-dihydroxyvitamin D (1,25D)/25-hydroxyvitamin D (25D) ratio for assessment of the extent of bone metabolism.MethodsWe retrospectively screened data for 87 patients whose serum 1,25D and 25D levels were measured. Eight patients who were taking vitamin D preparations were excluded, and data for 79 patients (33 males and 46 females) were analyzed. Since menopausal status can be associated with serum vitamin D level, we divided the patients by gender and divided the female patients into two groups at the age of 50 years.ResultsThe median serum 1,25D/25D ratio was significantly lower in males than in females, with the most considerable difference in all males [4.1 (interquartile range: 2.3-5.8) x 10(-3)] versus elderly females (aged >= 50 years) [7.9 (3.3-10.1) x 10(-3)). Main disorders were endocrine (30.6%), inflammatory (18.5%), and bone related (16.7%) disorders. The ratios of serum 1,25D/25D had significant negative correlations with femoral dual-energy X-ray absorptiometry % young adult mean (DEXA %YAM) (R=-0.35) and lumbar DEXA %YAM (R=-0.32). Significant correlations were found between the 1,25D/25D ratio and serum levels of inorganic phosphate (iP), parathyroid hormone, and alkaline phosphatase (ALP). The 1,25D/25D ratio had gender specific characteristics: the ratio was significantly correlated with age in males (R=-0.49), while it was significantly correlated with BMI in females (R=0.34).ConclusionsThe results of this study suggested that vitamin D activity is negatively correlated with bone mineral density, being reduced in aged males but enhanced in obese females.

DOI： 10.7759/cureus.18070

Web of Science

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：OKAYAMA UNIV MED SCHOOL  

Various laboratory markers of inflammation are utilized in general practice, but their clinical diagnostic significance is often ambiguous. In the present study, we determined the clinical significance of the examination of serum levels of procalcitonin (PCT) by comparing the PCT levels with the levels of other inflammatory markers, based on a retrospective review of 332 PCT-positive patients, including cases of bacterial infection (20.5%), non-specific inflammation (20.8%), neoplasm (9.9%), connective tissue diseases (8.4%), and non-bacterial infection (7.2%), were analyzed. The serum PCT level was highest in the bacterial infection group (1.94 ng/ml) followed by the non-specific inflammatory group (0.58 ng/ml) and neoplastic diseases group (0.34 ng/ml). The serum PCT level was positively correlated with serum levels of C-reactive protein (rho = 0.62), soluble interleukin-2 receptor (sIL-2R; rho = 0.69), and ferritin, the plasma level of D-dimer, and white blood cell count, and negatively correlated with the serum albumin level (rho = -0.52), hemoglobin concentration, and platelet count. The serum PCT level showed a stronger positive correlation with the serum sIL-2R level than the other biomarkers. The results suggest that an increased PCT level may indicate not only an infectious state but also a non-bacterial inflammatory condition in the diagnostic process in general practice.

DOI： 10.18926/AMO/62221

Web of Science

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：WILEY  

We report a case of isolated adrenocorticotropin deficiency caused by pembrolizumab. This condition can be fatal, but its rarity causes under-recognition. Oncologists should pay attention to adrenal insufficiency due to pembrolizumab.

DOI： 10.1002/ccr3.4305

Web of Science

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：ASSOC CLINICAL SCIENTISTS  

Objective. Urinary free cortisol (UFC) is a reliable marker to avoid cortisol fluctuation and the effects of binding proteins. However, UFC levels are affected by fluid intake and urine volume, and the normal levels range widely. Methods. To discover the utility of the ratio of urinary cortisol to aldosterone excretions, 246 patients in whom daily excretions of UFC and aldosterone (UAC) were measured were retrospectively analyzed. Results. The UFC/UAC ratio showed significant positive and negative correlations with the levels of serum cortisol (R=0.287) and aldosterone (R=-0.762), respectively. The UFC/UAC ratio increased with aging in female patients, while it was not altered by the level of BMI in either gender. Markers for metabolic and inflammatory status, including hemoglobin A1c (R=0.327), albumin (R=-0.331), C-reactive protein (R=0.317), ferritin (R=0.473), and D-dimer (R=0.569), showed correlations with the ratio of UFC/UAC that were more significant than the correlations with the serum level of cortisol or UFC alone. Of note, the UFC/UAC ratio was shown to be an indicator for the risk of diabetes (AUC: 0.765), hypoalbuminemia (0.839), hyper-CRPemia (0.748), and thrombophilia (0.824), in which the cut-off levels of the UFC/UAC ratio were around 12. Conclusion. The UFC/UAC ratio is a variable for detecting metabolic and inflammatory complications related to adrenocortical dysfunction.

Web of Science

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：BMJ PUBLISHING GROUP  

DOI： 10.1136/postgradmedj-2020-138416

Web of Science

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：OKAYAMA UNIV MED SCHOOL  

A 79-year-old woman presented to our hospital with a 10-day history of gradually worsening binocular vision and severe backache. Further investigations revealed poor bilateral best-corrected visual acuities (BCVA), bilateral vitreous opacities, gray-white lesions scattered throughout the retina, and a left iliopsoas abscess on CT that later grew out methicillin-sensitive S. aureus. The abscess was drained and intravenous antibiotics were initiated, but the left eye additionally required intravitreal vancomycin. BCVA for both eyes normalized within 1 year. Intramuscular abscess should be considered as a possible primary lesion in cases of endogenous bacterial endophthalmitis.

DOI： 10.18926/AMO/61909

Web of Science

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：OKAYAMA UNIV MED SCHOOL  

To determine the clinical characteristics of low androgen status in adult males with diabetes, we retrospectively analyzed the medical records of patients with type 2 diabetes mellitus in whom serum free testosterone (FT) levels were examined for 1 year. Among the 46 patients (56 +/- 1.5 years old), decreases in serum FT levels to <8.5 pg/ml (indicating the occurrence of late-onset hypogonadism [LOH]) were detected in 18 (39%). The percentages of patients with low FT levels were high in the >= 50 years age group (83%), the HbA1c <7% group (67%), and the 25 <= BMI < 30 kg/m(2) group (56%). The serum FT levels tended to decrease age-dependently. The level of HbA1c was significantly correlated with the Heinemann Aging Male Symptoms (AMS) score (R= 0.47). The low-FT group had decreased levels of hemoglobin. Of note, the serum FSH level (R = -0.32) was negatively correlated with the serum FT level, whereas the serum TSH level (R= 0.36) was positively correlated with the serum FT level. Collectively, these results revealed that many diabetic males may have low FT levels and that the AMS score is related to the HbA1c level. A slightly anemic condition, thyroid dysfunction, and obesity (class 1) might be involved in LOH in middle-aged diabetic males.

DOI： 10.18926/AMO/61424

Web of Science

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：JMIR PUBLICATIONS, INC  

Background: The COVID-19 pandemic has negatively affected medical education. However, little data are available about medical students' distress during the pandemic.Objective: This study aimed to provide details on how medical students have been affected by the pandemic.Methods: A cross-sectional study was conducted. A total of 717 medical students participated in the web-based survey. The survey included questions about how the participants' mental status had changed from before to after the Japanese nationwide state of emergency (SOE).Results: Out of 717 medical students, 473 (66.0%) participated in the study. In total, 29.8% (141/473) of the students reported concerns about the shift toward online education, mostly because they thought online education would be ineffective compared with in-person learning. The participants' subjective mental health status significantly worsened after the SOE was lifted (P<.001). Those who had concerns about a shift toward online education had higher odds of having generalized anxiety and being depressed (odds ratio [OR] 1.97, 95% CI 1.19-3.28) as did those who said they would request food aid (OR 1.99, 95% CI 1.16-3.44) and mental health care resources (OR 3.56, 95% CI 2.07-6.15).Conclusions: Given our findings, the sudden shift to online education might have overwhelmed medical students. Thus, we recommend that educators inform learners that online learning is not inferior to in-person learning, which could attenuate potential depression and anxiety.

DOI： 10.2196/25232

Web of Science

PubMed

researchmap

Language：English   Publisher：BMJ PUBLISHING GROUP  

DOI： 10.1136/postgradmedj-2020-139562

Web of Science

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：WILEY  

Primary effusion lymphoma (PEL) is a kind of malignant lymphoma that develops without a tumor mass. A fluid smear is of no use for the diagnosis of miscellaneous condition. Repeated cell-block smear with immunostaining is useful for the diagnosis of PEL.

DOI： 10.1002/ccr3.3469

Web of Science

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：ELSEVIER  

Antimicrobial resistance (AMR) is an urgent global issue. After the AMR action plan was introduced in 2016, a study on antibiotic literacy (i.e., awareness, knowledge, and attitude relating to antimicrobial use) among clinicians and lay people was conducted in Japan. However, no studies have hitherto targeted medical students who are expected to have a high level of antibiotic literacy. The present study was conducted between September 2019 and February 2020, enrolling undergraduate students at Okayama University Medical School. We collected data using a paper-based questionnaire form with 11 questions about antibiotic literacy. The response rate was 93.8% (661/705 students). Overall, 92.6% of the students knew that antibiotics inhibit the growth of bacteria. Student reporting that antibiotics could treat the common cold accounted for 77.0% (Year 1), 50.9% (Year 2), 48.2% (Year 3), 49.1% (Year 4), 23.8% (Year 5), and 26.2% (Year 6). Only 43 (6.5%) had heard about the AMR action plan. The study data suggested that medical students' level of literacy on antimicrobial use should be further enhanced to address AMR and promote antimicrobial stewardship. (C) 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

DOI： 10.1016/j.jiac.2020.06.021

Web of Science

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：OKAYAMA UNIV MED SCHOOL  

To clarify the relevance of prolactin (PRL) to clinical parameters in patients who visited our general medicine department, medical records of 353 patients in whom serum PRL levels were measured during the period from 2016 to 2018 were retrospectively reviewed. Data for 140 patients (M/F: 42/98) were analyzed after excluding patients lacking detailed records and patients taking dopaminergic agents. Median serum PRL levels were significantly lower in males than females: 6.5 ng/ml (IQR: 4.2-10.3) versus 8.1 ng/ml (5.9-12.9), respectively. Pain and general fatigue were the major symptoms at the first visit, and past histories of hypertension and dyslipidemia were frequent. Male patients with relatively high PRL levels (>= 10 ng/ml) had significantly lower levels of serum albumin and significantly higher levels of serum LDH than those with low PRL (< 10 ng/ml). There were significant correlations of male PRL level with the erythrocyte sedimentation rate (R=0.62), serum LDH level (R=0.39) and serum albumin level (R=-0.52), while the level of serum CRP (R=0.33) showed an insignificant but weak positive correlation with PRL level. Collectively, these results show that PRL levels had gender-specific relevance to various clinical factors, with PRL levels in males being significantly related to inflammatory status.

DOI： 10.18926/AMO/60797

Web of Science

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：ELSEVIER  

Mycobacterium chelonae is a rapidly growing mycobacterium that has the potential to cause refractory infections in humans. Mycobacteremia resulting from the organism is extremely rare, and its clinical features are yet to be uncovered. We herein present a case of M. chelonae bloodstream infection involving an immunocompromised older patient. A 79-year-old woman, on a long-term treatment with prednisolone plus tacrolimus for rheumatoid arthritis, visited our outpatient department complaining of deteriorating pain and swelling at her right 1st toe. Laboratory parameters showed elevated C-reactive protein and leukocytosis, and magnetic resonance imaging indicated osteomyelitis at the proximal phalanx of her right 1st toe. Considering the refractory course, the infected toe was immediately amputated. M. chelonae was isolated from bacterial cultures of the resected tissue and blood (BD BAC-TECT (TM) FX blood culture system, Becton Dickinson, Sparks, MD, USA), leading to a diagnosis of disseminated M. chelonae infection. We treated the patient with an antibiotic combination of clarithromycin, minocycline, and imipenem (2 weeks), which was converted to oral therapy of clarithromycin, doxycycline, and levofloxacin. This case highlighted the potential pathogenesis of M. chelonae to cause mycobacteremia in an immunocompromised patient. (C) 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

DOI： 10.1016/j.jiac.2020.03.004

Web of Science

PubMed

researchmap

Language：Japanese   Publisher：(一社)日本医学教育学会  

J-GLOBAL

researchmap

Other Link： https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2020&ichushi_jid=J00050&link_issn=&doc_id=20200708060052&doc_link_id=%2Fed9jmded%2F2020%2F005103%2F054%2F0320-0322%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fed9jmded%2F2020%2F005103%2F054%2F0320-0322%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

Language：English   Publishing type：Research paper (scientific journal)   Publisher：WILEY  

A 69-year-old Japanese man with a 10-year history of hemodialysis for end-stage renal disease presented with painful necrosis of the fingers of his right hand. A plain radiograph of the right hand revealed severely calcified arteries, particularly in the ring finger, suggesting the diagnosis of calciphylaxis of the fingers.

DOI： 10.1002/jgf2.296

Web of Science

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：WILEY  

Myxedema coma is an emergency presentation of hypothyroidism, and cardiopulmonary manifestations of the disease are related to a high mortality rate. We herein report a case of myxedema coma accompanied by sick sinus syndrome requiring temporary cardiac pacing and hypercapnic respiratory failure in an 87-year-old woman. This case is unique because both of the cardiac and pulmonary manifestations were reversible and successfully treated with thyroid hormone replacement. Our case indicates that early detection of the condition and administration of levothyroxine are essential to improve the life-threatening condition and avoid invasive treatment such as permanent pacemaker implantation or intubation.

DOI： 10.1002/jgf2.267

Web of Science

PubMed

researchmap

Language：Japanese   Publisher：岡山医学会  

researchmap

Language：Japanese   Publisher：沖縄県医師会医学会  

78歳女性。インフルエンザB型感染後、一旦は解熱したが、再度40℃の発熱を認め、湿性咳嗽や喀痰の増加、頻呼吸が出現したため当院へ救急外来となった。受診時、検査および胸部X線・CT、喀痰グラム染色より、インフルエンザウイルス感染に合併した黄色ブドウ球菌性肺炎と診断され、入院の上、バンコマイシン、セファゾリンの投与を開始した。入院2日目にMSSA菌血症が確認され、4日目に感受性の結果からバンコマイシンを中止し、その後は解熱し、徐々に呼吸状態の安定を認め、血液培養も陰性化し、抗菌薬は合計28日間使用し終了した。

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本内分泌学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本内分泌学会  

researchmap

Language：Japanese   Publisher：(一社)日本医学教育学会  

researchmap

Language：Japanese   Publisher：(一社)日本プライマリ・ケア連合学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：日本疲労学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：日本疲労学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：日本疲労学会  

researchmap

Language：Japanese   Publisher：(一社)日本プライマリ・ケア連合学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本内分泌学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本内分泌学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本内分泌学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本内分泌学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本内分泌学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本内科学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本内科学会  

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本内分泌学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(株)ライフメディコム  

新型コロナウイルス感染症(COVID-19)が最初に報告されてからおよそ1年半が経過したが、いまだ収束の兆しの見えない世界的流行のなかで「Long-COVID」ないし「post-acute sequelae of COVID-19(PASC)」と定義され、一般には「コロナ後遺症」として知られる、急性期以降に残存する症状に悩まされる患者が多く存在している。そのなかでも「倦怠感」は、最も多い症状として報告され、COVID-19罹患後に4割程度の患者が自覚すると言われている。倦怠感は視認できず検査での客観的評価も難しい症状である一方で、さまざまな要因が複雑に絡みあって生じており病態メカニズムも未解明なところが多く、診療に難渋する。われわれは2021年2月にLong-COVID/PASCを専門的に診療する「コロナ・アフターケア(COVID-19 aftercare:CAC)外来」を大学病院内にいち早く設立し、倦怠感などの症状に悩む患者の診療と研究・教育に取り組んできた。本稿ではそうしたわれわれの診療経験も踏まえ、診断や治療を行ううえでの対面診療の必要性や総合診療的アプローチの重要性についても触れながら、Long-COVID/PASCにおける倦怠感について概説する。(著者抄録)

researchmap

Language：Japanese   Publisher：(株)ライフメディコム  

新型コロナウイルス感染症(COVID-19)が最初に報告されてからおよそ1年半が経過したが、いまだ収束の兆しの見えない世界的流行のなかで「Long-COVID」ないし「post-acute sequelae of COVID-19(PASC)」と定義され、一般には「コロナ後遺症」として知られる、急性期以降に残存する症状に悩まされる患者が多く存在している。そのなかでも「倦怠感」は、最も多い症状として報告され、COVID-19罹患後に4割程度の患者が自覚すると言われている。倦怠感は視認できず検査での客観的評価も難しい症状である一方で、さまざまな要因が複雑に絡みあって生じており病態メカニズムも未解明なところが多く、診療に難渋する。われわれは2021年2月にLong-COVID/PASCを専門的に診療する「コロナ・アフターケア(COVID-19 aftercare:CAC)外来」を大学病院内にいち早く設立し、倦怠感などの症状に悩む患者の診療と研究・教育に取り組んできた。本稿ではそうしたわれわれの診療経験も踏まえ、診断や治療を行ううえでの対面診療の必要性や総合診療的アプローチの重要性についても触れながら、Long-COVID/PASCにおける倦怠感について概説する。(著者抄録)

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本内分泌学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本内分泌学会  

researchmap

Language：Japanese   Publisher：(一社)日本内分泌学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：間脳・下垂体・副腎系研究会  

70歳代、男性。下咽頭癌肺転移に対するペンブロリズマブの投与中に発熱や食思不振、嘔吐が持続し、精査目的で当科へ紹介となった。不明熱に対しての内分泌学的精査を施行し、ACTH単独欠損症(IAD)と診断され、ヒドロコルチゾン10mg/日の補充を開始したところ、症状・炎症反応の速やかな改善が得られた。病歴から本症例におけるIADの原因はペンブロリズマブによる免疫関連有害事象と考えられ、同薬剤の投与を中止することで、中止後も転移病変は縮小を維持している。

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本医学教育学会  

researchmap

Language：Japanese   Publisher：(株)メディカル・サイエンス・インターナショナル  

＜文献概要＞key point ▼不定愁訴は造語であり,肩こりやだるさなど,主訴が特定できない「不定」の症状を指すものと考えられる。▼不定愁訴から疑うべき内分泌疾患として,女性は更年期障害,男性はLOH症候群がある。▼更年期障害やLOH症候群は,症状コントロールに漢方薬が有効なことがある。

J-GLOBAL

researchmap

Language：Japanese   Publisher：(株)メディカル・サイエンス・インターナショナル  

＜文献概要＞key point ▼全身倦怠感は非特異的な主訴であるが,その原因となる内分泌疾患は診断・治療が確立しており,確定診断を行う意義は大きい。▼全身倦怠感をみた場合は,内分泌疾患として副腎不全,甲状腺機能低下症,甲状腺機能亢進症,成長ホルモン分泌不全症,更年期障害/LOH症候群の可能性を考慮する。▼全身倦怠感はlow yieldな主訴であり,それ以外の症候や検査値異常に注意する。

J-GLOBAL

researchmap

Language：Japanese   Publisher：日本消化器病学会-中国支部  

J-GLOBAL

researchmap

Language：Japanese  

J-GLOBAL

researchmap

Language：Japanese  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本内分泌学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本内分泌学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本内分泌学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本内分泌学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本内分泌学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本内分泌学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(株)診断と治療社  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本内分泌学会  

J-GLOBAL

researchmap

Language：Japanese  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本内分泌学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(株)南江堂  

J-GLOBAL

researchmap

Other Link： https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2021&ichushi_jid=J00974&link_issn=&doc_id=20201224150029&doc_link_id=issn%3D0022-1961%26volume%3D127%26issue%3D1%26spage%3D148&url=http%3A%2F%2Fwww.pieronline.jp%2Fopenurl%3Fissn%3D0022-1961%26volume%3D127%26issue%3D1%26spage%3D148&type=PierOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00005_2.gif

J-GLOBAL

researchmap

J-GLOBAL

researchmap

Language：Japanese   Publisher：(株)中外医学社  

J-GLOBAL

researchmap

Language：Japanese   Publisher：日本疲労学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本内分泌学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：大道学館出版部  

J-GLOBAL

researchmap

Other Link： https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2020&ichushi_jid=J01556&link_issn=&doc_id=20201020280015&doc_link_id=%2Fam3daidc%2F2020%2F009710%2F015%2F1273-1276%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fam3daidc%2F2020%2F009710%2F015%2F1273-1276%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

Language：Japanese   Publisher：(一社)日本内分泌学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本医学教育学会  

researchmap

Language：Japanese   Publisher：(株)医学書院  

J-GLOBAL

researchmap

Other Link： https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2020&ichushi_jid=J06514&link_issn=&doc_id=20200706220019&doc_link_id=10.11477%2Fmf.1429202695&url=https%3A%2F%2Fdoi.org%2F10.11477%2Fmf.1429202695&type=%88%E3%8F%91.jp_%83I%81%5B%83%8B%83A%83N%83Z%83X&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00024_2.gif

Language：Japanese  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(株)診断と治療社  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本内分泌学会  

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本病院総合診療医学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本病院総合診療医学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本総合病院精神医学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本内分泌学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本医学教育学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本病院総合診療医学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本病院総合診療医学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本病院総合診療医学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本病院総合診療医学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本病院総合診療医学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本病院総合診療医学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本病院総合診療医学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本内分泌学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(株)羊土社  

(1)検査をオーダーするときは鑑別疾患ありき。そのうえで検査を選ぼう(2)直列検査と並列検査、検査閾値と治療閾値という考え方を身につける(3)カットオフ値、検査の感度と特異度で診断の有用性を考える(4)検査前確率と検査後確率、尤度比で最終的な診断を導く(著者抄録)

J-GLOBAL

researchmap

Other Link： https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2019&ichushi_jid=J03286&link_issn=&doc_id=20190312220003&doc_link_id=%2Fai4resic%2F2019%2F002101%2F004%2F0022-0030%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fai4resic%2F2019%2F002101%2F004%2F0022-0030%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

Language：Japanese   Publisher：(株)医学書院  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(株)医学書院  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(株)羊土社  

＜Point＞●診断困難症例への考え方:直感的思考と分析的思考、そして除外診断の重要性を理解しよう●他診療科との協力は、鑑別診断のためなのか、検査目的なのか、治療介入が必要なのか、目的を明確に伝える●「症例くん」と「PINACO」は、同様の症例を検索するのに便利●それでも診断がつかないときでも、患者の気持ちに寄り添い、患者への説明を十分に行う(著者抄録)

J-GLOBAL

researchmap

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本病院総合診療医学会  

researchmap

Language：Japanese   Publisher：(一社)日本病院総合診療医学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本内分泌学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本医学教育学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(NPO)日本血管外科学会  

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

Language：Japanese   Publisher：沖縄県医師会医学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：沖縄県医師会医学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本病院総合診療医学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)米国内科学会日本支部  

researchmap

Language：Japanese   Publisher：沖縄県医師会医学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本医学教育学会  

researchmap

Language：Japanese   Publisher：(一社)日本医学教育学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：沖縄県医師会医学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本医学教育学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本医学教育学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本医学教育学会  

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本医学教育学会  

J-GLOBAL

researchmap

J-GLOBAL

researchmap

Event date： 2023.11.3 - 2023.11.4

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.11.3 - 2023.11.4

Language：Japanese  

researchmap

Event date： 2023.11.3 - 2023.11.4

Language：Japanese  

researchmap

Event date： 2023.11.3 - 2023.11.4

Language：Japanese  

researchmap

Event date： 2023.10.27

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.10.27

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.10.21

Language：Japanese  

researchmap

Event date： 2023.10.2

Language：Japanese   Presentation type：Public lecture, seminar, tutorial, course, or other speech  

researchmap

Event date： 2023.9.2

Language：Japanese  

researchmap

Event date： 2023.9.2

Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.8.27

Language：Japanese  

researchmap

Event date： 2023.8.26 - 2023.8.27

Language：Japanese  

researchmap

Event date： 2023.8.26 - 2023.8.27

Language：Japanese  

researchmap

Event date： 2023.8.26 - 2023.8.27

Language：Japanese  

researchmap

Event date： 2023.8.26

Language：Japanese  

researchmap

Event date： 2023.7.28 - 2023.7.30

Language：Japanese   Presentation type：Public lecture, seminar, tutorial, course, or other speech  

researchmap

Event date： 2023.7.28 - 2023.7.30

Language：Japanese  

researchmap

Event date： 2023.7.28 - 2023.7.30

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.7.28 - 2023.7.30

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.7.28 - 2023.7.30

Language：Japanese   Presentation type：Public lecture, seminar, tutorial, course, or other speech  

researchmap

Event date： 2023.6.15 - 2023.6.18

Language：English  

researchmap

Event date： 2023.6.15 - 2023.6.18

Language：English  

researchmap

Event date： 2023.6.1 - 2023.6.3

researchmap

Event date： 2023.6.1 - 2023.6.3

Language：Japanese  

researchmap

Event date： 2023.5.21

Language：Japanese  

researchmap

Event date： 2023.5.21

Language：Japanese  

researchmap

Event date： 2023.5.21

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.5.21

Language：Japanese  

researchmap

Event date： 2023.5.21

Language：Japanese  

researchmap

Event date： 2023.3.2 - 2023.3.4

Language：Japanese   Presentation type：Symposium, workshop panel (nominated)  

researchmap

Event date： 2023.2.18 - 2023.2.19

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.2.18 - 2023.2.19

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.2.18 - 2023.2.19

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.11.26 - 2022.11.27

Language：Japanese  

researchmap

Event date： 2022.11.11 - 2022.11.12

Language：Japanese  

researchmap

Event date： 2022.11.11 - 2022.11.12

Language：Japanese  

researchmap

Event date： 2022.10.30

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.8.27 - 2022.8.31

Language：English   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.8.5 - 2022.8.6

Language：Japanese   Presentation type：Public lecture, seminar, tutorial, course, or other speech  

researchmap

Event date： 2022.8.5 - 2022.8.6

Language：Japanese   Presentation type：Public lecture, seminar, tutorial, course, or other speech  

researchmap

Event date： 2022.8.5 - 2022.8.6

Language：Japanese  

researchmap

Event date： 2022.7 - 2022.9

Language：Japanese   Presentation type：Public lecture, seminar, tutorial, course, or other speech  

researchmap

Event date： 2022.6.11 - 2022.6.14

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2022.6.2 - 2022.6.4

Language：Japanese  

researchmap

Event date： 2022.6.2 - 2022.6.4

Language：Japanese  

researchmap

Event date： 2022.6.2 - 2022.6.4

Language：Japanese  

researchmap

Event date： 2022.6.2 - 2022.6.4

Language：Japanese  

researchmap

Event date： 2022.4.15 - 2022.4.17

Language：Japanese  

researchmap

Event date： 2022.4.15 - 2022.4.17

Language：Japanese  

researchmap

Event date： 2022.4.9 - 2022.4.22

Language：Japanese  

researchmap

Event date： 2022.2.26 - 2022.2.27

Language：Japanese  

researchmap

Event date： 2022.2.26 - 2022.2.27

Language：Japanese  

researchmap

Event date： 2022.2.26 - 2022.2.27

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.2.26 - 2022.2.27

Language：Japanese  

researchmap

Event date： 2022.2

Language：Japanese  

researchmap

Event date： 2021.11.27

Language：Japanese  

researchmap

Event date： 2021.11.26 - 2021.11.27

Language：Japanese  

researchmap

Event date： 2021.11.26 - 2021.11.27

Language：Japanese  

researchmap

Event date： 2021.9.18 - 2021.10.1

Language：Japanese  

70歳代、男性。下咽頭癌肺転移に対するペンブロリズマブの投与中に発熱や食思不振、嘔吐が持続し、精査目的で当科へ紹介となった。不明熱に対しての内分泌学的精査を施行し、ACTH単独欠損症(IAD)と診断され、ヒドロコルチゾン10mg/日の補充を開始したところ、症状・炎症反応の速やかな改善が得られた。病歴から本症例におけるIADの原因はペンブロリズマブによる免疫関連有害事象と考えられ、同薬剤の投与を中止することで、中止後も転移病変は縮小を維持している。

researchmap

Event date： 2021.9.4

Language：Japanese  

researchmap

Event date： 2021.8.27 - 2021.8.30

Language：English   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.8.27 - 2021.8.30

Language：English   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.7.31

Language：Japanese  

researchmap

Event date： 2021.7.29 - 2021.8.1

Language：Japanese   Presentation type：Symposium, workshop panel (nominated)  

researchmap

Event date： 2021.6.12 - 2021.6.13

Language：Japanese  

researchmap

Event date： 2021.5.21 - 2021.5.23

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.5.21 - 2021.5.23

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.4.24

Language：Japanese  

researchmap

Event date： 2021.4.24

Language：Japanese  

researchmap

Event date： 2021.4.24

Language：Japanese  

researchmap

Event date： 2021.4.22 - 2021.4.24

Language：Japanese  

researchmap

Event date： 2021.4.22 - 2021.4.24

Language：Japanese  

researchmap

Event date： 2021.4.22 - 2021.4.24

Language：Japanese  

researchmap

Event date： 2021.4.22 - 2021.4.24

Language：Japanese  

researchmap

Event date： 2021.2.19 - 2021.2.28

researchmap

Event date： 2020.11.13 - 2020.11.14

Language：Japanese  

researchmap

Event date： 2020.11.7 - 2020.11.8

Language：Japanese  

researchmap

Event date： 2020.6.4 - 2020.6.6

Language：Japanese  

researchmap

Event date： 2020.2.22

Language：Japanese  

researchmap

Event date： 2020.2.21 - 2020.2.22

Language：Japanese  

researchmap

Event date： 2019.11.29 - 2019.11.30

Language：Japanese  

researchmap

Event date： 2019.11.15 - 2019.11.16

Language：Japanese  

researchmap

Event date： 2019.11

Language：Japanese  

researchmap

Event date： 2019.10.25 - 2019.10.26

Language：Japanese  

researchmap

Event date： 2019.9.14 - 2019.9.15

Language：Japanese  

researchmap

Event date： 2019.7

Language：Japanese  

researchmap

Event date： 2019.5

Language：Japanese  

researchmap

Event date： 2019.5

Language：Japanese  

researchmap

Event date： 2019.5

Language：Japanese  

researchmap

Event date： 2019.5

Language：Japanese  

researchmap

Event date： 2019.5

Language：Japanese  

researchmap

Event date： 2019.5

Language：Japanese  

researchmap

Event date： 2019.5

Language：Japanese  

researchmap

Event date： 2019.4

Language：Japanese  

researchmap

Event date： 2019.1.9 - 2019.1.13

Language：English   Presentation type：Oral presentation (general)  

researchmap

Event date： 2019

researchmap

Event date： 2018.11

Language：Japanese  

researchmap

Event date： 2018.11

Language：Japanese  

researchmap

Event date： 2018.9

Language：Japanese  

researchmap

Event date： 2018.7

Language：Japanese  

researchmap

Event date： 2018.6

Language：Japanese  

researchmap

Event date： 2018

researchmap

Event date： 2018

researchmap

Event date： 2018

researchmap

Event date： 2017.12

Language：Japanese  

researchmap

Event date： 2017.12

Language：Japanese  

researchmap

Event date： 2017.7

Language：Japanese  

researchmap

Event date： 2017.6

Language：Japanese  

researchmap

Event date： 2017

Language：Japanese  

researchmap

Event date： 2016.7

Language：Japanese  

researchmap

Event date： 2015.7

Language：Japanese  

researchmap

Event date： 2014.12

Language：Japanese  

researchmap

Event date： 2014.7

Language：Japanese  

researchmap

Event date： 2012.7

Language：Japanese  

researchmap

Event date： 2012.7

Language：Japanese  

researchmap

Event date： 2012.7

Language：Japanese  

researchmap

Event date： 2012

researchmap

Language：English   Presentation type：Public lecture, seminar, tutorial, course, or other speech  

researchmap

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Language：Japanese   Presentation type：Public lecture, seminar, tutorial, course, or other speech  

researchmap

Language：Japanese   Presentation type：Symposium, workshop panel (nominated)  

researchmap

Language：Japanese   Presentation type：Symposium, workshop panel (nominated)  

researchmap

Language：Japanese   Presentation type：Symposium, workshop panel (nominated)  

researchmap

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Language：Japanese   Presentation type：Public lecture, seminar, tutorial, course, or other speech  

researchmap

Language：Japanese   Presentation type：Symposium, workshop panel (nominated)  

researchmap

Language：Japanese   Presentation type：Symposium, workshop panel (nominated)  

researchmap

Language：English  

researchmap

Language：English  

researchmap

researchmap

researchmap

researchmap

researchmap

researchmap